SS Innovations International Files 8-K

Ticker: SSII · Form: 8-K · Filed: Jul 31, 2024 · CIK: 1676163

Sentiment: neutral

Topics: disclosure, financial-statements, exhibits

TL;DR

SS Innovations International (SSIN) filed an 8-K on July 31st for an event on July 23rd, including financial statements.

AI Summary

SS Innovations International, Inc. filed an 8-K on July 31, 2024, reporting an event on July 23, 2024. The filing is a Regulation FD Disclosure and includes Financial Statements and Exhibits. The company, formerly known as AVRA Medical Robotics, Inc., is incorporated in Florida and headquartered in Fort Lauderdale.

Why It Matters

This 8-K filing provides important updates and disclosures for SS Innovations International, Inc., which could impact investor understanding of the company's current status and regulatory compliance.

Risk Assessment

Risk Level: low — This filing is a standard 8-K disclosure and does not appear to contain significant negative news or events.

Key Numbers

Key Players & Entities

FAQ

What specific event occurred on July 23, 2024, that necessitated this 8-K filing?

The filing indicates it is a Regulation FD Disclosure and includes Financial Statements and Exhibits, but the specific event triggering the July 23rd date is not detailed in the provided text.

What is the primary business of SS Innovations International, Inc.?

The company is classified under Standard Industrial Classification code 3841, which is SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

When did SS Innovations International, Inc. change its name from AVRA Medical Robotics, Inc.?

The date of the name change was June 1, 2016.

Where are the principal executive offices of SS Innovations International, Inc. located?

The principal executive offices are located at 1600 SE 15th Street, #512, Fort Lauderdale, Florida 33316.

What type of disclosures are included in this 8-K filing?

This 8-K filing includes disclosures related to Regulation FD and also contains Financial Statements and Exhibits.

Filing Stats: 556 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-07-31 16:05:48

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On July 23, 24 and 25, 2024, we conducted live and online demonstrations in New York City to introduce our SSi Mantra-3 Surgical Robotic System to the media, industry analysts and the investment community . Attached as Exhibit 99.1 to this Report is a copy of the presentation used by the Company in connection with the demonstrations it conducted. The foregoing information, including the presentation attached as Exhibit 99.1 to this Report, is being furnished pursuant to Item 7.01 of this Report and shall not be deemed " filed " for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended or incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Furnished but not filed. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: July 31, 2024 SS INNOVATIONS INTERNATIONAL, INC. By: /s/ Sudhir Srivastava Sudhir Srivastava, M.D. Chairman and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing